Invasive fungal infections in Chile: a multicenter study of fungal prevalence and susceptibility during a 1-year period

References

• Banerjee SN, Emori TG, Culver DH, et al. Secular trends in nosocomial primary bloodstream infections in the United States, 1980–1989. Am J Med 1980; 91(Suppl. 3B): 86–89.
   Google Scholar
• Edmond MB, Wallace SE, McClish DK, et al. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis 1999; 29: 239–244.
   PubMed Web of Science ®Google Scholar
• Beck-Sagué CM, Jarvis WR and the National Nosocomial Infections Surveillance System. Secular trends in the epidemiology of nosocomial infections in the United States, 1980-1990. J Infect Dis 1993; 167: 1247–1251.
   Google Scholar
• Jarvis WR. Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin Infect Dis 1995; 20: 1526–1530.
   PubMed Web of Science ®Google Scholar
• Rees JR, Pinner RW, Hajjeh RA, Brandt ME, Reingold AL. The epidemiological features of invasive mycotic infections in the San Francisco Bay area, 1992-1993: results of a population based laboratory active surveillance. Clin Infect Dis 1998; 27: 1138–1147.
   Google Scholar
• MacDonald L, Baker C, Chenoeth C. Risk factors for candidemia in a children's hospital. Clin Infect Dis 1998; 26: 642–645.
   PubMed Web of Science ®Google Scholar
• Otaiza F, Brenner P. Informe De Vigilancia Epidemiologica De Las Infecciones Intrahospitalarias, Chile — 1997–1998. Santiago: Gobierno de Chile, Ministerio de Salud, 1999.
   Google Scholar
• Pound MW, Drew RH, Perfect JR. Recent advances in the epidemiology prevention, diagnosis and treatment of fungal pneumonia. Curr Opin Infect Dis 2002; 15: 183–194.
   PubMed Web of Science ®Google Scholar
• Pfaller AM, Diekema DJ, Jones RN, et al. International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to flucona-zole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program. J Clin Microbiol 1997; 39: 3254–3259.
   Google Scholar
• Colombo AL. Epidemiology and treatment of hematogenous candidiasis: a Brazilian perspective. Braz J Infect Dis 2000; 4: 113–118.
   PubMedGoogle Scholar
• Girmenia C, Martino P, De Bernardis F, et al. Rising incidence of Candida parapsilosis fungemia in patients with hematologic malignancies: clinical aspects, predisposing factors, and differen-tial pathogenicity of the causative strains. Clin Infect Dis 1996; 23: 506–514.
   PubMed Web of Science ®Google Scholar
• Levy L, Rubin LG, Vasishtha S, Tucci V, Sood SK. Emergence of Candida parapsilosis as the predominant species causing candi-demia in children. Clin Infect Dis 1998; 26: 1086–1088.
   Google Scholar
• Nolla-Salas J, Sitges-Serra JA, Leon-Gil C, et al. Candidemia in non-neutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy. Study group of fungal infections in ICU. Intensive Care Med 1997; 23: 23–30.
   PubMedGoogle Scholar
• Rodero L, Davel G, Córdoba S, Soria M, Cantero C, Hochenfeller F. Multicenter study on nosocomial candidiasis in the Republic of Argentina. Rev Argent Microbiol 1999; 31: 114–119.
   PubMedGoogle Scholar
• Sandven P, Bevanger L, Digranes A, et al. Constant low rate of fungemia in Norway, 1991 to 1996. J Clin Microbiol 1998; 36: 3455–3459.
   PubMed Web of Science ®Google Scholar
• St-Germain G, Lavendiere M, Pelletier R, et al. Prevalence and antifungal susceptibility of 442 Candida isolates from blood and normally sterile sites: results of a 2-year (1996 to 1998) multicenter surveillance study in Quebec, Canada. J Clin Microbiol 2001; 39: 949–953.
   Google Scholar
• Welbel SF, McNeil MM, Kuykendall RJ, et al. Candida parapsilosis bloodstream infections in neonatal intensive care unit patients; epidemiological laboratory confirmation of a common source outbreak. Pediatr Infect Dis J 1996; 15: 998–1002.
   PubMed Web of Science ®Google Scholar
• Hoog GS, Guarro J, eds. Atlas of Clinical Fungi. Baar and Delft — Reus: Centraalbureau voor Schimmelcultures—Universitat Rovira i Virgili, 1996.
   Google Scholar
• Yarrow D. Methods for the isolation, maintenance and identifica-tion of yeasts. In: Kurtzman CP, Fell JW (eds). The Yeasts: A Taxonomic Study, 6th edn. Amsterdam: Elsevier, 1998: 75–107.
   Google Scholar
• Silva V, Pires MF, Fischman 0. In vitro maintenance of dermatophytes in gelatin disc. Program and Abstracts of the 13th Congress of the International Society for Human and Animal Mycology ( ISHAM) . Salsomaggiore-Terme, Parma, Italy. 1997; Abstr. P399, University of Parma, Italy.
   Google Scholar
• National Committee for Clinical Laboratory Standards. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. Approved Standard M 27-A. Wayne, PA: National Committee for Clinical Laboratory Standards, 1997.
   Google Scholar
• Alvarado D, Diaz MC, Silva V. Identification and antifungal susceptibility of Candida spp. isolated from invasive mycosis. Influence of growth inhibition percentage to determine minimal inhibitory concentration. Rev Med Chile 2002; 130: 416–423.
   Google Scholar
• Pfaller AM, Messer SA, Coffmann S. Comparison of visual and spectrophotometric methods of MIC endpoint determinations by using broth microdilution methods to test five antifungal agents, including the new triazole D 0870. J Clin Microbiol 1995; 33: 1094–1097.
   Google Scholar
• Rex JH, Pfaller MA, Lancaster M, et al. Quality control guidelines for national committee for clinical laboratory stan-dards-recommended broth macrodilution testing of ketoconazole and itraconazole. J Clin Microbiol 1996; 34: 816–817.
   PubMed Web of Science ®Google Scholar
• Rex JH, Pfaller MA, Galgiani JN, et al. Development of interpretative breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro—in vivo correlation data for fluconazole, itraconazole, and Candida infections. Clin Infect Dis 1997; 24: 235–247.
   PubMed Web of Science ®Google Scholar
• Pfaller AM, Jones RN, Doern GV, et al. Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997-1998. Ant imicrob Agents Chemother 2000; 44: 747–751.
   PubMed Web of Science ®Google Scholar
• Silva V, Zepeda G, Rybac ME, Febré N. Yeast carriage on the hands of Medicine's students. Rev Iberoam Micol 2003; 20:41–45.
   Google Scholar
• Parapoch J, Planes AM, Querol A, et al. Fungemia with Saccharomyces cerevisiae in two newborns, only one of whom had been treated with ultra-levura. Eur J Clin Microbiol Infect Dis 2000; 19: 468 —470.
   Google Scholar
• Ruiz-Esquide F, Diaz MC, Wu E, Silva V. Saccharomyces cerevisiae endocarditis in a preterm infant. Report of one case. Rev Med Chile 2002; 130: 1165–1169.
   Google Scholar
• Wolf DG, Folk R, Hacham M, et al. Multidrug resistance in Trichosporon asahii from nongranulocytopenic patients in three intensive care units. J Clin Microbiol 2000; 139: 4420–4425.
   Google Scholar